BHST (BioHarvest Sciences, Inc.) Projected Sales Volume

Graphic logo of BioHarvest Sciences, Inc. (BHST)

BioHarvest Sciences (BHST) is developing cellular biopharmaceuticals by outsourcing raw materials and processing to reduce costs. The valuation of the organization's future sales on the GURU.Markets terminal linear chart contains up-to-date data, where the current status is 0.03. This price action reflects the scaling of the VINIA system and entry into the US market, supported by a stable team of scientists with no turnover in R&D.

BHST - BioHarvest Sciences Company Future Sales over the range 11/13/2024 - 11/16/2026

Financial and market metric breakdowns for BioHarvest (BHST)

- stock value and consensus price forecast:
Comprehensive company analysis:BHST BioHarvest Sciences Inc.
Brand item of BioHarvest Sciences, Inc.

This metric measures the real dynamics of business expansion, stripping actual market share growth of marketing expectations and accounting adjustments. By analyzing this sales benchmark for BioHarvest Sciences (BHST), an investor can assess the extent to which the scaling of automated bioreactors is transitioning from the technological development stage to a stage of physical volume increases in cellular biomass sales.

Direct competitors

Projected Sales Volume HLN|KVUE (Kenvue Inc) - Company Future Revenue|Verona Pharma Corp - Company Future Sales Volume|Company Projected Revenue Volume MENS (Jyong Biotech Ltd)|ligand.com - Projected Sales Volume|amneal.com (AMRX) - Company Future Sales Volume|Perrigo (PRGO) - Company Projected Revenue|ALVO (Alvotech S.A.) - Company Projected Revenue|Company Future Sales Volume LQDA|Projected Sales Volume Galapagos Corp|Company Projected Revenue ANI Pharma (ANIP)|Projected Sales Volume MannKind Corporation (MNKD)|Company Projected Revenue Amphastar Pharmaceuticals Inc AMPH|Projected Sales Volume Pacira PCRX|ARS Pharmaceuticals Inc - Projected Sales Volume|TBPH - Projected Sales Volume|AQST (Aquestive Therapeutics) - Company Future Sales Volume|scPharmaceuticals, Inc. (SCPH) - Projected Sales Volume|Company Future Sales Volume TECX|Projected Sales Volume Tonix Pharma|Company Future Sales Volume SXTC (SXT Pharmaceuticals)|EPRX: Company Expected Revenue|Company Projected Revenue eXoZymes EXOZ|Company Future Revenue ORMP|ENTX - Company Projected Revenue|HYFT: Company Projected Revenue|ABVC BioPharma, Inc (ABVC) - Company Projected Revenue|Cumberland Pharma - Company Future Revenue|QNTM (Quantum BioPharma Corp) - Projected Sales Volume|FibroGen, Inc. - Company Expected Revenue|Projected Sales Volume TELO|Company Future Sales Rani Therapeutics Holdings, Inc.|Company Projected Revenue Synergy CHC Corp. SNYR|Projected Sales Volume rallybio.com RLYB|Lexaria Bioscience Corp. - Projected Sales Volume|PULM: Company Projected Revenue|PTHL (ftzy.com.cn) - Company Future Sales Volume|APM: Company Projected Revenue Volume|LYRA (Lyra Therapeutics Inc) - Projected Sales Volume|Company Revenue Forecast IBO (Impact BioMedical)|Company Future Sales Volume TNFA (TNF Pharmaceuticals)|Projected Sales Volume cbdMD Corp (YCBD)|Projected Sales Volume PRFX (PainReform)|Company Future Sales Auris Medical (CYTO)|LIPO - Company Projected Revenue|Optinose (OPTN) - Company Future Sales Volume|Pieris (PIRS) - Company Projected Revenue|Company Expected Revenue PROC (Procaps Group S.A.)|Company Future Sales Volume PTPI|QLI: Company Future Revenue|Company Projected Revenue acelyrin.com (SLRN)|TFFP (TFF Pharma) - Company Future Revenue